News and Trends 11 Oct 2016 World Mental Health Day: How is Biotech Helping the Cause? …lead candidate, LMTX, positioning it as one of the most advanced Alzheimer’s treatments. The therapy aims to dissolve the protein aggregates responsible for the disease progression at the molecular level…. October 11, 2016 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 24 Feb 2023 Resalis Therapeutics receives €10M to develop obesity and NAFLD treatment …our lead candidate and provides an orthogonal approach to other therapeutics.” About Resalis Therapeutics’ RES-10 Resalis Therapeutics’ lead candidate RES-10 is an antisense oligonucleotide (ASO) that targets miR-22, a central… February 24, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 18 Apr 2023 Gene therapy: a powerful tool for hemophilia B? …yet to be determined and further research is required to confirm the candidate’s durability. Another drug candidate is multinational pharmaceutical Pfizer’s collaboration with Swiss biopharma Roche. Fidanacogene elaparvovec, which is… April 18, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 13 Nov 2017 British Biotech Gets PRIME Designation for its Brittle Bones Drug …portfolio contains four clinical‑stage candidates, including BPS-804 for the treatment of osteogenesis imperfecta. The candidate has been given Prime Designation by the EMA, which means Mereo will receive scientific advice… November 13, 2017 - 1 minutemin - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 17 Feb 2017 UPDATE: More Promising Results from Mologen’s New HIV Therapy …The candidate will now be tested in combination with neutralizing antibodies developed by Rockefeller University in New York thanks to a €2.6M ($2.75M) grant from Gilead, which is also working… February 17, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 9 Aug 2022 Pfizer and Valneva to start phase 3 Lyme disease vaccine study …disease vaccine candidate, VLA15. “With increasing global rates of Lyme disease, providing a new option for people to help protect themselves from the disease is more important than ever,” said… August 9, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 22 Oct 2025 Deal after deal: Novartis spends billions in 2025 …get its hands on Tourmaline’s candidate pacibekitug. It targets IL-6, a cytokine – small proteins that regulate the immune system – that contributes to inflammation and is implicated in the progression of atherosclerotic cardiovascular disease… October 22, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 May 2023 Six women’s health companies you should know about …(HER2-) breast cancer. But unlike other treatment methods, Atossa’s candidate does not suppress ovarian function. The company’s proprietary drug (Z)-endoxifen is a tamoxifen metabolite (hormone therapy drug). Tamoxifen, according to… May 18, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jan 2018 Swiss Biotech Gets $339M to Boost the Development of Drug Addiction Therapies …biotech’s drug addiction pipeline. The agreement covers Addex’s candidate, ADX71441, and Indivior will also support research into further indications for the candidate. The news has seen Addex’s stock price rocket… January 3, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2023 Sensorion and EVEON collaborating on injection system to deliver gene therapy inner ear treatments …to develop an injection system for the safe and effective delivery of our gene therapy candidates,” said Geraldine Honnet, chief medical officer of Sensorion. “Our delivery system is intended to… January 31, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jun 2023 Quell in potential $2B AstraZeneca cell therapy deal …the option to further develop and commercialize successful candidates, with Quell Therapeutics responsible for the process development and manufacturing of clinical candidates through to the end of the first-in-human clinical… June 9, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Sponsored by Indivumed Therapeutics 8 Oct 2024 How an innovative, data-driven approach is revolutionizing drug discovery for solid tumors …identify new therapeutic targets and potential drug candidates. Current therapies for solid tumors remain suboptimal, often resulting in poor clinical outcomes and severe side effects. Progress in finding new therapies… October 8, 2024 - 6 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email